The odds ratio and adjusted odds ratio are preferable alternatives when conducting a meta-analysis to assess the potential of VEGF-A as a predictive blood-based biomarker, or data sharing of deidentified raw data, time points, and ROP outcomes. This evidence concerns the gene VEGFA and retinopathy of prematurity.